| OSMAX | OSMYX | OSMAX / OSMYX | |
| Total Expense Ratio | 1.42 | 1.18 | 120% |
| Annual Report Gross Expense Ratio | 1.42 | 1.18 | 120% |
| Fund Existence | 29 years | 21 years | - |
| Gain YTD | 10.366 | 10.559 | 98% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.41B | 2.41B | 100% |
| Annual Yield % from dividends | 1.32 | 1.57 | 84% |
| Returns for 1 year | -7.75 | -7.73 | 100% |
| Returns for 3 years | 1.28 | 1.71 | 75% |
| Returns for 5 years | -37.76 | -37.26 | 101% |
| Returns for 10 years | 7.36 | 9.29 | 79% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XJAN | 39.16 | -0.04 | -0.10% |
| FT Vest US Eq Enh & Mod Buf ETF-Jan | |||
| MSLC | 60.85 | -0.24 | -0.39% |
| Morgan Stanley Pathway Large Cap Eq ETF | |||
| BINV | 45.37 | -0.23 | -0.50% |
| Brandes International ETF | |||
| PQUS | 28.41 | -0.19 | -0.65% |
| Pictet AI Enhanced US Equity ETF | |||
| WDNA | 22.73 | -0.35 | -1.52% |
| WisdomTree BioRevolution ETF | |||